Funding for this research was provided by:
Beckman Coulter Foundation (Project Number CA9353)
Text and Data Mining valid from 2020-05-05
Received: 5 February 2020
Accepted: 13 April 2020
First Online: 5 May 2020
Ethics approval and consent to participate
: In keeping with Food and Drug Administration standards for establishing a biomarker, an honest broker protocol was used to obtain de-identified research data such that informed consent was waived. The protocol was approved by the Western Institutional Review Board, Inc. (protocol # C03747).
: Not applicable.
: Authors EDC and JEP were supported by a grant from Beckman Coulter, Inc. to perform the clinical trial. Authors DTH, PH, and TO have consulting agreements with Beckman Coulter, Inc. IG, DC, MH, and LT are employees of Beckman Coulter, Inc., the sponsor of the project.